ActX offers a service that analyzes genetic information in real time. CompuGroup Medical US is a global provider of healthcare software solutions. As per the partnership, ActX will integrate real-time genomic decision support tools into CGM’s EHR solutions — CGM webEHR and CGM CLINICAL.
ActX will build a full genomic profile in the patient’s chart. Providers will be able to check prescriptions for efficacy, adverse reactions and appropriate dosing. Additionally, it will alert the provider when non-medication genomic risks are found.
“We are excited to make precision medicine a reality for users of CGM’s EHR solutions,” said Andrew Ury MD, CEO of ActX in a statement. “CGM is a global market leader in EHR software and services, and we’re proud to be offering genomic decision support to the company’s physician customer base, within their normal workflow.”
More articles on health IT:
T2 Tech Group hires former Grady Health System CIO Bill Wilson
Global telemedicine market to hit $113B+ by 2025: 4 trends to note
Privacy issues drive health IT consumer skepticism: 10 Black Book survey findings
